Fighting Relapsing Multiple Sclerosis With Copaxone - www.informationsecuritysummit.org

Fighting Relapsing Multiple Sclerosis With Copaxone - opinion

Multiple sclerosis begins when a patient is as young as It can start with blurry vision, tingling in the arms or legs, or a persistent feeling of tiredness. MS is a long-term, progressive disease that worsens over time, but there are few drugs available today. Even worse, patients diagnosed with a less common form of MS known as primary progressive multiple sclerosis have no treatments available at all. However, this harsh reality might change soon with the emergence of a new drug called Ocrelizumab. Fighting Relapsing Multiple Sclerosis With Copaxone

Several medications called disease-modifying treatments DMTs or disease-modifying drugs DMDs have been shown to be effective in decreasing the frequency of relapses or exacerbations and decreasing the development of lesions or plaques in the brain or spinal cord.

Disease-modifying treatments

Disease-modifying therapies have been shown to reduce the frequency and severity of MS attacks, or relapses. DMTs can slow the accumulation of MS lesions in the brain and spinal cord and can slow the progression of disability.

There are several DMTs approved by the U. Many of these medications are considered to be first-line options, in other words, the initial choice of drug therapy for treating patients who Scclerosis diagnosed with MS. Others are second-line drug treatment options in the US, which Scelrosis that Fighting Relapsing Multiple Sclerosis With Copaxone are reserved for people who have not responded adequately to first-line drugs. With so many disease-modifying-therapies available, it is important to know the differences between these drugs so that you and your doctor might select one over another for your treatment. Others are second-line treatment options for persons who have not responded adequately to a first-line drug. By providing your email address, you are agreeing to our privacy policy.

We never sell or share your email address. Good news - you're already subscribed! Need help? Let us know at contact MultipleSclerosis. An error occurred.

Post navigation

Try again or reach out to contact MultipleSclerosis. Disease-Modifying Treatments for MS. CIS, relapsing-remitting, active secondary progressive, and primary progressive MS. You're all set! Written by Emily Downward Last review date: March View References Luzzio C. Olek MJ. Disease-modifying treatment of relapsing multiple sclerosis in adults.

Mayo Clinic. Betaseron prescribing information. Avonex prescribing information. Rebif prescribing information.

Extavia prescribing information. Plegridy prescribing information.

Opening the lines of communication between research scientists and the wider community

Copaxone prescribing information. Tysabri prescribing information. Lemtrada prescribing information. Ocrevus prescribing information. Tecfidera prescribing information.]